SR-BI inhibits ABCG1-stimulated net cholesterol efflux from cells to plasma HDL
Open Access
- 1 January 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Lipid Research
- Vol. 49 (1), 107-114
- https://doi.org/10.1194/jlr.m700200-jlr200
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivoJCI Insight, 2007
- Inhibition of Cholesteryl Ester Transfer Protein by Torcetrapib Modestly Increases Macrophage Cholesterol Efflux to HDLArteriosclerosis, Thrombosis, and Vascular Biology, 2007
- Effect of Torcetrapib on the Progression of Coronary AtherosclerosisNew England Journal of Medicine, 2007
- Selective uptake of HDL cholesteryl esters and cholesterol efflux from mouse peritoneal macrophages independent of SR-BIJournal of Lipid Research, 2006
- Tissue-Specific Induction of Intestinal ABCA1 Expression With a Liver X Receptor Agonist Raises Plasma HDL Cholesterol LevelsCirculation Research, 2006
- HDL from CETP-deficient subjects shows enhanced ability to promote cholesterol efflux from macrophages in an apoE- and ABCG1-dependent pathwayJCI Insight, 2006
- Dual Role for Scavenger Receptor Class B, Type I on Bone Marrow-Derived Cells in Atherosclerotic Lesion DevelopmentThe American Journal of Pathology, 2004
- Sterol regulation of scavenger receptor class B type I in macrophagesJournal of Lipid Research, 2004
- Tangier disease as a test of the reverse cholesterol transport hypothesisJCI Insight, 2000
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989